Kato, H.; Hagihara, M.; Asai, N.; Hirai, J.; Yamagishi, Y.; Iwamoto, T.; Mikamo, H.
Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis. Antibiotics 2022, 11, 1291.
https://doi.org/10.3390/antibiotics11101291
AMA Style
Kato H, Hagihara M, Asai N, Hirai J, Yamagishi Y, Iwamoto T, Mikamo H.
Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis. Antibiotics. 2022; 11(10):1291.
https://doi.org/10.3390/antibiotics11101291
Chicago/Turabian Style
Kato, Hideo, Mao Hagihara, Nobuhiro Asai, Jun Hirai, Yuka Yamagishi, Takuya Iwamoto, and Hiroshige Mikamo.
2022. "Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis" Antibiotics 11, no. 10: 1291.
https://doi.org/10.3390/antibiotics11101291
APA Style
Kato, H., Hagihara, M., Asai, N., Hirai, J., Yamagishi, Y., Iwamoto, T., & Mikamo, H.
(2022). Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis. Antibiotics, 11(10), 1291.
https://doi.org/10.3390/antibiotics11101291